COVID-19 in multiple sclerosis patients and risk factors for severe infection

Multiple sclerosis (MS) patients have been considered a higher-risk population for COVID-19 due to the high prevalence of disability and disease-modifying therapy use; however, there is little data identifying clinical characteristics of MS associated with worse COVID-19 outcomes. Therefore, we cond...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaudhry, Farhan, Bulka, Helena, Rathnam, Anirudha S., Said, Omar M., Lin, Jia, Lorigan, Holly, Bernitsas, Eva, Rube, Jacob, Korzeniewski, Steven J., Memon, Anza B., Levy, Phillip D., Schultz, Lonni, Javed, Adil, Lisak, Robert, Cerghet, Mirela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834402/
https://www.ncbi.nlm.nih.gov/pubmed/32980780
http://dx.doi.org/10.1016/j.jns.2020.117147

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834402/
https://www.ncbi.nlm.nih.gov/pubmed/32980780
http://dx.doi.org/10.1016/j.jns.2020.117147

Ejemplares similares